HIGH SUSTAINED VIROLOGICAL RESPONSE (SVR) RATE WITH DANOPREVIR FOR ONLY 14 DAYS ASSOCIATED WITH PEG-INTERFERON-ALPHA-2A AND RIBAVIRIN IN TREATMENT CHRONIC HCV GENOTYPE 1 PATIENTS
Journal of Hepatology(2011)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要